Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.
Dyskeratosis congenita (DC) is a pediatric bone marrow failure syndrome caused by germline mutations in telomere biology genes. Mutations in DKC1 (the most commonly mutated gene in DC), the 3′ region of TERC, and poly(A)-specific ribonuclease (PARN) cause reduced levels of the telomerase RNA component (TERC) by reducing its stability and accelerating TERC degradation. We have previously shown that depleting wild-type DKC1 levels by RNA interference or expression of the disease-associated A353V mutation in the DKC1 gene leads to decay of TERC, modulated by 3′-end oligoadenylation by noncanonical poly(A) polymerase 5 (PAPD5) followed by 3′ to 5′ degradation by EXOSC10. Furthermore, the constitutive genetic silencing of PAPD5 is sufficient to rescue TERC levels, restore telomerase function, and elongate telomeres in DKC1_A353V mutant human embryonic stem cells (hESCs). Here, we tested a novel PAPD5/7 inhibitor (RG7834), which was originally discovered in screens against hepatitis B viral loads in hepatic cells. We found that treatment with RG7834 rescues TERC levels, restores correct telomerase localization in DKC1 and PARN-depleted cells, and is sufficient to elongate telomeres in DKC1_A353V hESCs. Finally, treatment with RG7834 significantly improved definitive hematopoietic potential from DKC1_A353V hESCs, indicating that the chemical inhibition of PAPD5 is a potential therapy for patients with DC and reduced TERC levels.
Citations by journals
1
2
|
|
Journal of Clinical Medicine
|
Journal of Clinical Medicine
2 publications, 8.33%
|
Blood
|
Blood
2 publications, 8.33%
|
Biomedicines
|
Biomedicines
1 publication, 4.17%
|
Science
|
Science
1 publication, 4.17%
|
Frontiers in Pharmacology
|
Frontiers in Pharmacology
1 publication, 4.17%
|
Nature Reviews Genetics
|
Nature Reviews Genetics
1 publication, 4.17%
|
npj Genomic Medicine
|
npj Genomic Medicine
1 publication, 4.17%
|
Trends in Molecular Medicine
|
Trends in Molecular Medicine
1 publication, 4.17%
|
Journal of Biological Chemistry
|
Journal of Biological Chemistry
1 publication, 4.17%
|
Environmental Toxicology and Pharmacology
|
Environmental Toxicology and Pharmacology
1 publication, 4.17%
|
FEBS Letters
|
FEBS Letters
1 publication, 4.17%
|
Biochemistry and Cell Biology
|
Biochemistry and Cell Biology
1 publication, 4.17%
|
Chemical Reviews
|
Chemical Reviews
1 publication, 4.17%
|
Expert Review of Hematology
|
Expert Review of Hematology
1 publication, 4.17%
|
Nucleic Acids Research
|
Nucleic Acids Research
1 publication, 4.17%
|
Journal of Cell Biology
|
Journal of Cell Biology
1 publication, 4.17%
|
RNA
|
RNA
1 publication, 4.17%
|
Cell Reports
|
Cell Reports
1 publication, 4.17%
|
Biochemical Society Transactions
|
Biochemical Society Transactions
1 publication, 4.17%
|
Food Frontiers
|
Food Frontiers
1 publication, 4.17%
|
1
2
|
Citations by publishers
1
2
3
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 12.5%
|
Elsevier
|
Elsevier
3 publications, 12.5%
|
Springer Nature
|
Springer Nature
2 publications, 8.33%
|
Wiley
|
Wiley
2 publications, 8.33%
|
American Society of Hematology
|
American Society of Hematology
2 publications, 8.33%
|
American Association for the Advancement of Science (AAAS)
|
American Association for the Advancement of Science (AAAS)
1 publication, 4.17%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
1 publication, 4.17%
|
American Society for Biochemistry and Molecular Biology
|
American Society for Biochemistry and Molecular Biology
1 publication, 4.17%
|
Canadian Science Publishing
|
Canadian Science Publishing
1 publication, 4.17%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
1 publication, 4.17%
|
Taylor & Francis
|
Taylor & Francis
1 publication, 4.17%
|
Oxford University Press
|
Oxford University Press
1 publication, 4.17%
|
Rockefeller University Press
|
Rockefeller University Press
1 publication, 4.17%
|
Cold Spring Harbor Laboratory
|
Cold Spring Harbor Laboratory
1 publication, 4.17%
|
Portland Press
|
Portland Press
1 publication, 4.17%
|
1
2
3
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.